These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 1545249)

  • 21. Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study.
    Ohman J; Servo A; Heiskanen O
    J Neurosurg; 1991 Jan; 74(1):14-20. PubMed ID: 1984496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery.
    Ohman J; Servo A; Heiskanen O
    J Neurosurg; 1991 Jan; 74(1):8-13. PubMed ID: 1984511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Woodworth GF; Ali M; Than KD; Tamargo RJ; Clatterbuck RE
    J Neurosurg; 2007 Dec; 107(6):1080-5. PubMed ID: 18077943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage.
    Tachibana E; Harada T; Shibuya M; Saito K; Takayasu M; Suzuki Y; Yoshida J
    Acta Neurochir (Wien); 1999; 141(1):13-9. PubMed ID: 10071681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined drug therapy with diltiazem, dextran, and hydrocortisone (DDH therapy) for late cerebral vasospasm after aneurysmal subarachnoid hemorrhage: assessment of efficacy and safety in an open clinical study.
    Kawano T; Kazekawa K; Nakashima S; Kohno H; Tanaka N; Honma T; Kaneko Y; Satoh K
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):513-7. PubMed ID: 8520810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment of transient focal cerebral ischemia in rats with the calcium antagonist AT877.
    Ohtaki M; Tranmer B
    Stroke; 1994 Jun; 25(6):1234-9; discussion 1240. PubMed ID: 8202986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
    Siironen J; Juvela S; Varis J; Porras M; Poussa K; Ilveskero S; Hernesniemi J; Lassila R
    J Neurosurg; 2003 Dec; 99(6):953-9. PubMed ID: 14705720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of clot removal on cerebral vasospasm.
    Inagawa T; Yamamoto M; Kamiya K
    J Neurosurg; 1990 Feb; 72(2):224-30. PubMed ID: 2295920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value and determinants of ultraearly angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
    Qureshi AI; Sung GY; Suri MA; Straw RN; Guterman LR; Hopkins LN
    Neurosurgery; 1999 May; 44(5):967-73; discussion 973-4. PubMed ID: 10232529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.
    Tokiyoshi K; Ohnishi T; Nii Y
    Surg Neurol; 1991 Aug; 36(2):112-8. PubMed ID: 1891755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage.
    Flamm ES; Adams HP; Beck DW; Pinto RS; Marler JR; Walker MD; Godersky JC; Loftus CM; Biller J; Boarini DJ
    J Neurosurg; 1988 Mar; 68(3):393-400. PubMed ID: 3343611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
    Senbokuya N; Kinouchi H; Kanemaru K; Ohashi Y; Fukamachi A; Yagi S; Shimizu T; Furuya K; Uchida M; Takeuchi N; Nakano S; Koizumi H; Kobayashi C; Fukasawa I; Takahashi T; Kuroda K; Nishiyama Y; Yoshioka H; Horikoshi T
    J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial.
    Asano T; Takakura K; Sano K; Kikuchi H; Nagai H; Saito I; Tamura A; Ochiai C; Sasaki T
    J Neurosurg; 1996 May; 84(5):792-803. PubMed ID: 8622153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
    Kassell NF; Haley EC; Apperson-Hansen C; Alves WM
    J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage.
    Howington JU; Kutz SC; Wilding GE; Awasthi D
    J Neurosurg; 2003 Aug; 99(2):271-5. PubMed ID: 12924699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
    Desbordes JM; Ades PE; Guggiari M
    Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage.
    Kaminogo M; Yonekura M; Onizuka M; Yasunaga A; Shibata S
    Neurol Med Chir (Tokyo); 1998 Nov; 38(11):704-8; discussion 708-9. PubMed ID: 9919901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.
    Seiler RW; Grolimund P; Zurbruegg HR
    Acta Neurochir (Wien); 1987; 85(1-2):7-16. PubMed ID: 2955675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.